You need to enable JavaScript to run this app.
Recon: Eli Lilly Profit Boosted by Trulicity Demand; Roche Posts 2019 Growth Despite Biosimilar Competition
Recon
Michael Mezher
ReconMichael Mezher
ReconMichael Mezher